» Articles » PMID: 37773272

MR1 Antigen Presentation to MAIT Cells and Other MR1-restricted T Cells

Overview
Journal Nat Rev Immunol
Date 2023 Sep 29
PMID 37773272
Authors
Affiliations
Soon will be listed here.
Abstract

MHC antigen presentation plays a fundamental role in adaptive and semi-invariant T cell immunity. Distinct MHC molecules bind antigens that differ in chemical structure, origin and location and present them to specialized T cells. MHC class I-related protein 1 (MR1) presents a range of small molecule antigens to MR1-restricted T (MR1T) lymphocytes. The best studied MR1 ligands are derived from microbial metabolism and are recognized by a major class of MR1T cells known as mucosal-associated invariant T (MAIT) cells. Here, we describe the MR1 antigen presentation pathway: the known types of antigens presented by MR1, the location where MR1-antigen complexes form, the route followed by the complexes to the cell surface, the mechanisms involved in termination of MR1 antigen presentation and the accessory cellular proteins that comprise the MR1 antigen presentation machinery. The current road map of the MR1 antigen presentation pathway reveals potential strategies for therapeutic manipulation of MR1T cell function and provides a foundation for further studies that will lead to a deeper understanding of MR1-mediated immunity.

Citing Articles

MAIT cells modulating the oral lichen planus immune microenvironment: a cellular crosstalk perspective.

Mi Q, Wu X, Chen Y, Meng W Inflamm Res. 2025; 74(1):10.

PMID: 39762617 DOI: 10.1007/s00011-024-01990-6.


Mucosal associated invariant T cells: Powerhouses of the lung.

Lopez-Rodriguez J, Barral P Immunol Lett. 2024; 269:106910.

PMID: 39128630 PMC: 11835791. DOI: 10.1016/j.imlet.2024.106910.


Regulation of MAIT cells through host-derived antigens.

Ito E, Yamasaki S Front Immunol. 2024; 15:1424987.

PMID: 38979423 PMC: 11228242. DOI: 10.3389/fimmu.2024.1424987.


RNAseq of INOCA patients identifies innate, invariant, and acquired immune changes: potential autoimmune microvascular dysfunction.

Jaatinen K, Shah P, Mazhari R, Hayden Z, Wargowsky R, Jepson T Front Cardiovasc Med. 2024; 11:1385457.

PMID: 38978787 PMC: 11228317. DOI: 10.3389/fcvm.2024.1385457.


Immune Cytolytic Activity and Strategies for Therapeutic Treatment.

Agioti S, Zaravinos A Int J Mol Sci. 2024; 25(7).

PMID: 38612436 PMC: 11011457. DOI: 10.3390/ijms25073624.


References
1.
Dickson L, Liu S, Storrie B . Rab6 is required for rapid, cisternal-specific, intra-Golgi cargo transport. Sci Rep. 2020; 10(1):16604. PMC: 7538953. DOI: 10.1038/s41598-020-73276-w. View

2.
Yamaguchi H, Hirai M, Kurosawa Y, Hashimoto K . A highly conserved major histocompatibility complex class I-related gene in mammals. Biochem Biophys Res Commun. 1997; 238(3):697-702. DOI: 10.1006/bbrc.1997.7379. View

3.
Eggensperger S, Tampe R . The transporter associated with antigen processing: a key player in adaptive immunity. Biol Chem. 2015; 396(9-10):1059-72. DOI: 10.1515/hsz-2014-0320. View

4.
Smith A, Foss E, Zhang I, Hastie J, Giordano N, Gasparyan L . Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection. PLoS One. 2019; 14(9):e0223025. PMC: 6764671. DOI: 10.1371/journal.pone.0223025. View

5.
Tsukamoto K, Deakin J, Marshall Graves J, Hashimoto K . Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. Immunogenetics. 2012; 65(2):115-24. DOI: 10.1007/s00251-012-0666-5. View